Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by newdaydawningon Sep 05, 2019 4:16pm

90 Views

Post# 30099738

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:... a Theralase Board ....

Wow, it looks even better when you consider that the warrants are actually priced at $0.085, not $0.215. In other words, the current market cap is decidedly lower than you suggested.

2b7f6fab wrote: Let's pick a time frame, In May/June time frame TLT.v was trading around .45 cents CDN. with 147 million share outstanding = $66 million market cap with no cash in the bank. Today TLT.v trades at .22 with 266 million shares and tradable warrants outstanding = 59 million market cap with $15 million in the bank. Looks like a much better investment today than a few months ago. Hang tight.

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal